How Long After Being Exposed to TB Will You Test Positive?

Most people who become infected with tuberculosis will test positive on a skin test or blood test somewhere between two and eight weeks after exposure, though the full window can stretch to twelve weeks or occasionally longer. The immune system needs time to mount the specific response that TB tests detect, and that lag creates a gap between the day you breathe in the bacteria and the day a test can pick it up. How long that gap lasts depends on the type of test, the strength of your immune system, and how heavy the exposure was.

Why There Is a Delay at All

Neither the tuberculin skin test (TST) nor the blood-based interferon-gamma release assay (IGRA) looks for TB bacteria directly. Both tests detect your immune system’s reaction to TB proteins. After you inhale Mycobacterium tuberculosis, the bacteria settle in the lungs and begin interacting with immune cells. Your body’s adaptive immune response, specifically the T cells trained to recognize TB, takes time to build up to a level that a test can measure. That cellular immune response can typically be detected two to six weeks after infection.

1Frontiers in Pediatrics. Immune Response to Mycobacterium tuberculosis: A Narrative Review

The World Health Organization describes this gap as a “window period” of up to twelve weeks during which a skin test would be negative even in someone who is genuinely infected.

2WHO TB Knowledge Sharing Platform. Annex 2. Tuberculin skin testing: administration, reading and interpretation

This is why public health departments tell you not to test too early. If you get a skin test the day after sitting next to someone with active TB, the result will almost certainly be negative regardless of whether you were infected. Your T cells simply have not had enough time to mobilize.

What the Conversion Timeline Looks Like in Practice

The standard advice from most guidelines is to wait eight to ten weeks after your last known exposure before getting tested. That timing was chosen because most people who are going to convert will have done so by then, and it avoids the heartbreak of a false negative from testing too soon. But the real-world data shows a wider spread than that neat window implies.

In a study that tracked close contacts of TB patients with serial blood tests, IGRA conversion generally happened four to seven weeks after exposure. However, some people converted as late as fourteen to twenty-two weeks after their last contact with the source case.

3European Respiratory Journal. Time interval to conversion of interferon-γ release assay after exposure to tuberculosis

A more recent study found even later conversions, with some occurring up to twenty-five weeks after the last exposure. The researchers specifically noted that these findings suggest clinicians should consider repeating the blood test at a longer interval than the currently recommended eight to ten weeks.

4European Respiratory Journal. Time interval for QuantiFERON-TB Gold Plus conversion after last exposure with tuberculosis

So while the standard eight-to-ten-week guideline catches most conversions, it misses a meaningful number of people who convert later. If your initial test at eight weeks is negative but you had significant exposure, a second test at around six months can catch those late converters.

Skin Test Versus Blood Test

You will likely be offered one of two types of tests: the tuberculin skin test (TST, sometimes called the Mantoux test or PPD test) or an IGRA blood test such as QuantiFERON-TB Gold Plus or T-SPOT.TB. Both detect the immune response rather than the bacteria, but they work differently and have distinct quirks that affect timing and accuracy.

The skin test involves injecting a small amount of tuberculin protein under the skin of your forearm and then reading the size of any raised bump 48 to 72 hours later. The blood tests draw a tube of blood, stimulate the white blood cells with TB-specific proteins in a lab, and measure the amount of interferon-gamma those cells produce. Both types of IGRA show excellent agreement with each other: in one contact investigation, the two main commercial blood tests agreed about 94% of the time.

5PubMed. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis

Where the two approaches diverge most is in their susceptibility to false positives from the BCG vaccine and from other environmental mycobacteria. The skin test uses purified protein derivative, which contains proteins shared by the BCG vaccine strain and by many non-TB mycobacteria found in soil and water. If you received a BCG vaccination (standard in much of the world outside the United States), your skin test can light up even though you were never infected with TB. One study found that BCG-vaccinated people had seven times the odds of testing positive on a skin test while testing negative on a blood test, compared to unvaccinated people.

6JAMA. Comparison of a Whole-Blood Interferon γ Assay With Tuberculin Skin Testing for Detecting Latent Mycobacterium tuberculosis Infection

The blood tests use antigens called ESAT-6 and CFP-10, which are not present in BCG or in most non-TB mycobacteria, so they largely sidestep the false-positive problem. When researchers compared the two methods in BCG-unvaccinated contacts during a Danish school outbreak, agreement between the skin test and the modified blood test was 94%, confirming that the discrepancy in vaccinated populations is driven by BCG, not by poor test performance.

7American Journal of Respiratory and Critical Care Medicine. Comparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis Contacts

The practical upshot: if you were vaccinated with BCG, a blood test gives a much clearer picture of whether you are actually infected. If you were not vaccinated, both tests perform comparably, though the blood test is simpler since it requires only one visit instead of two.

The Booster Effect and Two-Step Skin Testing

There is a peculiar wrinkle with the skin test that can look like a late conversion but is actually something different. Some people carry a faded immune memory to TB proteins, either from a very old infection or from exposure to non-TB mycobacteria in the environment. Their first skin test comes back negative because the response has waned. But the act of receiving the test itself “reminds” the immune system, and a second skin test a week or two later suddenly comes back positive. This is called the booster phenomenon.

In a study of adolescents in a high-TB-prevalence setting in India, about 13% of those with initially small reactions showed a boosted response on a repeat test.

8PubMed Central. Two-Step Tuberculin Skin Testing in School-Going Adolescents with Initial 0-4 Millimeter Responses in a High Tuberculosis Prevalence Setting in South India

The distinction matters for how you interpret results. A boosted reaction reflects old sensitization, not a new infection. If someone does not boost when retested at one week but then turns positive a year later, that later result should be treated as a new infection.

9American Review of Respiratory Disease. The Booster Phenomenon in Serial Tuberculin Testing

This is why many workplaces that require annual TB testing for healthcare workers use a “two-step” baseline: you get a skin test, and if it is negative, you repeat it one to three weeks later. The second result becomes your true baseline. Any future conversion above that baseline is treated as a new infection. Blood tests are not affected by the booster phenomenon since they do not involve injecting anything that could stimulate a recall response.

Non-TB Mycobacteria and False Positives on the Skin Test

Beyond BCG, exposure to non-tuberculous mycobacteria (NTM) found in soil, water, and dust can prime the immune system in a way that makes a skin test react even in the absence of actual TB infection. Research evaluating this effect in children found that previous NTM sensitization caused false-positive skin test results, and that blood tests could avoid unnecessary preventive treatment in those cases.

10European Respiratory Journal. Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis

This is a bigger issue in tropical and subtropical regions where NTM are more abundant in the environment. A BCG-vaccinated person living in a warm climate may carry a double burden of cross-reactivity from both the vaccine and environmental bacteria. In one study of BCG-vaccinated healthcare workers, the skin test identified almost 89% as having latent TB, while the blood test flagged only about 15%.

11PubMed. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country

That gap is enormous and tells you just how unreliable the skin test can be in certain populations. If you live in a country where BCG vaccination is routine and NTM exposure is common, a positive skin test alone is not strong evidence that you are infected with TB. A follow-up blood test can separate genuine TB infection from background noise.

How Immunosuppression Changes Everything

Both the skin test and the blood test depend on a functioning immune system. If your immune system is weakened, particularly by HIV, you may never test positive even if you are genuinely infected. In an Ethiopian study, skin test reactivity was about 41% among people living with HIV compared to about 69% among HIV-negative individuals.

12PubMed Central. Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia

This condition, called anergy, means the immune system is too suppressed to mount the detectable response that tests rely on. The TB bacteria may be present, but the alarm bells stay silent. Antiretroviral therapy (ART) can reverse this effect. In a South African study, 22% of people living with HIV converted to a positive skin test within six months of starting ART, and an additional 12% converted between six and twelve months on treatment. Those with higher CD4 cell counts at baseline were more likely to convert.

13AIDS. High conversion of tuberculin skin tests during the first year of antiretroviral treatment among South African adults in primary care

This creates a tricky clinical scenario. If you test negative while immunosuppressed, the negative result may be meaningless. And if you test positive months later after starting treatment, it could mean a new infection, or it could mean your recovering immune system is finally reacting to an infection you have been carrying all along. Among HIV-positive gold miners in South Africa who were heavily exposed to TB, about a quarter resisted conversion on both skin and blood tests throughout follow-up, and having a higher CD4 count actually made people less likely to resist conversion.

14PubMed Central. Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa

Other forms of immunosuppression can cause similar problems. People on TNF-alpha inhibitors for autoimmune conditions, transplant recipients on anti-rejection drugs, and those receiving certain cancer treatments may all have blunted test responses. If you fall into any of these categories, a negative test after TB exposure deserves extra caution rather than reassurance.

How Much Exposure Actually Matters

Not everyone who breathes the same air as a person with active TB gets infected. The risk depends heavily on how much time you spent in close proximity and the conditions of that contact. A large analysis of contact investigations found that the likelihood of testing positive for latent TB increased by about 8% for every 250 additional hours of exposure. Below 250 total hours, the infection rate did not change much with additional time, suggesting a threshold effect.

15PubMed Central. Duration of Exposure Among Close Contacts of Patients With Infectious Tuberculosis and Risk of Latent Tuberculosis Infection

Household contacts who shared a bedroom with the person who had TB were at highest risk, followed by household members who slept in a different room, with non-household contacts at lowest risk. A study of childhood TB exposure constructed a contact score based on factors like sleeping proximity, duration of contact, and the infectiousness of the source case. For each one-point increase in the score, the odds of a child being infected rose by 74%.

16PubMed Central. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection

This matters for the testing timeline because low-intensity exposures, like sitting near someone with TB on a single bus ride, carry a much lower infection risk than weeks of sharing a household. Public health departments prioritize contact investigation resources toward close, prolonged contacts for exactly this reason. If your exposure was brief and casual, the chances that you need to worry about a delayed positive test are considerably smaller.

What Happens While You Wait for the Test

For young children, the window period is not just an inconvenience; it is a genuine danger. Children under five are more likely than adults to progress rapidly from infection to serious, even life-threatening TB disease. Because of this, many pediatric TB guidelines recommend starting preventive treatment immediately after a significant exposure, without waiting for a positive test. This is called “window prophylaxis.”

A review of the practice in Houston found that the threshold for starting window prophylaxis in exposed young children should be low, given the safety of the medications involved and the difficulty of predicting which children will progress.

17PubMed Central. Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017

The child is typically retested after the window period. If the second test is negative and the child has been taking preventive medication, treatment can be stopped. If the test is positive, treatment continues for the full course. For adults, the decision is more nuanced. Healthy adults exposed to TB are generally retested at eight to ten weeks and treated only if that test is positive, unless they are immunosuppressed or have other risk factors for rapid progression.

From Infection to Active Disease

A positive test after exposure means you have been infected, but it does not mean you are sick or contagious. Most people with latent TB infection never develop active disease. The risk of progression is highest in the first year or two after infection and then drops sharply. Among contacts who did develop active TB in one large study, about half were diagnosed within the first month after the source case was identified, three-quarters by three months, and over 90% within a year.

18PubMed Central. Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis

A study following healthcare workers who were exposed to TB found that among those who eventually developed active disease, the majority were diagnosed within the first year, though sporadic cases continued to appear over the following three years. Lower body weight and prolonged contact duration were independent predictors of who progressed.

19PLOS ONE. Regular Sputum Check-Up for Early Diagnosis of Tuberculosis after Exposure in Healthcare Facilities

This is the rationale behind treating latent TB infection even though you feel perfectly fine. The medications given during latent infection dramatically reduce the chance that the bacteria will reactivate and cause full-blown disease down the road. If your test converts to positive, your doctor will usually recommend a chest X-ray to rule out active TB, followed by a course of preventive therapy lasting anywhere from three to nine months depending on the regimen.

When Testing Gets Complicated in Cross-Border Settings

TB epidemiology varies dramatically from country to country, and this creates real headaches for interpreting test results. In low-burden countries like the United States or Denmark, a positive skin test in an adult who was never vaccinated with BCG is a reasonably reliable signal. But in countries where BCG is given at birth and TB circulates widely, distinguishing new infection from old vaccination or environmental exposure becomes genuinely difficult. A study in Lima, Peru found that the median time from TB transmission to disease was about seven months among household contacts, illustrating how quickly TB can move through communities with high background exposure.

20American Journal of Respiratory and Critical Care Medicine. Who Transmits Tuberculosis to Whom: A Cross-Sectional Analysis of a Cohort Study in Lima, Peru

If you have recently immigrated from a high-burden country or traveled to one for an extended period, the interpretation of your test depends heavily on context. A blood test is generally preferred over a skin test in this situation because it cuts through the noise from BCG and environmental mycobacteria. Your provider will also want to know when you were last in a high-burden setting, whether you had close contact with anyone who was coughing, and whether you have symptoms like a persistent cough, night sweats, or unintentional weight loss. The testing timeline does not change, but the urgency and interpretation of results can shift considerably based on your personal risk profile.